Rankings
▼
Calendar
DFTX Q4 2020 Earnings — Definium Therapeutics, Inc. Revenue & Financial Results | Market Cap Arena
DFTX
Definium Therapeutics, Inc.
$2B
Q4 2020 Earnings
Healthcare
Medical - Pharmaceuticals
Income Statement
Revenue
$0
Gross Profit
$0
Operating Income
-$33M
Net Income
-$13M
EPS (Diluted)
$-0.48
QoQ Revenue Growth
NaN%
Cash Flow
Operating Cash Flow
-$7M
Free Cash Flow
-$7M
Stock-Based Comp.
$5M
Balance Sheet
Total Assets
$82M
Total Liabilities
$6M
Stockholders' Equity
$76M
Cash & Equivalents
$80M
← FY 2020
All Quarters
Q1 2021 →
